BR9602630A - Acido7-([1alfa,5alfa,6alfa])-6-amino-3-azabiciclo[3.1.0.]hex-3-il)-6-flúor-1-(2,4-difluorofenil)-1,4-di-hidro-4-oxo-1,8-naftiridina-3-carboxílico, composção farmacêutica método de tratamento de uma infecção bacteriana e processo para a preparação do composto - Google Patents

Acido7-([1alfa,5alfa,6alfa])-6-amino-3-azabiciclo[3.1.0.]hex-3-il)-6-flúor-1-(2,4-difluorofenil)-1,4-di-hidro-4-oxo-1,8-naftiridina-3-carboxílico, composção farmacêutica método de tratamento de uma infecção bacteriana e processo para a preparação do composto

Info

Publication number
BR9602630A
BR9602630A BR9602630A BR9602630A BR9602630A BR 9602630 A BR9602630 A BR 9602630A BR 9602630 A BR9602630 A BR 9602630A BR 9602630 A BR9602630 A BR 9602630A BR 9602630 A BR9602630 A BR 9602630A
Authority
BR
Brazil
Prior art keywords
acido7
6alpha
5alpha
1alpha
naphthyridine
Prior art date
Application number
BR9602630A
Other languages
English (en)
Inventor
Thomas A Morris
Timothy Norris
Phillip J Johnson
Lynne A Handanyan
Robert L Hendrickson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9602630A publication Critical patent/BR9602630A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9602630A 1995-06-06 1996-06-04 Acido7-([1alfa,5alfa,6alfa])-6-amino-3-azabiciclo[3.1.0.]hex-3-il)-6-flúor-1-(2,4-difluorofenil)-1,4-di-hidro-4-oxo-1,8-naftiridina-3-carboxílico, composção farmacêutica método de tratamento de uma infecção bacteriana e processo para a preparação do composto BR9602630A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (1)

Publication Number Publication Date
BR9602630A true BR9602630A (pt) 1998-09-08

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9602630A BR9602630A (pt) 1995-06-06 1996-06-04 Acido7-([1alfa,5alfa,6alfa])-6-amino-3-azabiciclo[3.1.0.]hex-3-il)-6-flúor-1-(2,4-difluorofenil)-1,4-di-hidro-4-oxo-1,8-naftiridina-3-carboxílico, composção farmacêutica método de tratamento de uma infecção bacteriana e processo para a preparação do composto

Country Status (38)

Country Link
US (1) US5763454A (pt)
EP (1) EP0789697B1 (pt)
JP (1) JP3145715B2 (pt)
KR (1) KR100191989B1 (pt)
CN (1) CN1055474C (pt)
AR (1) AR002753A1 (pt)
AU (1) AU703634B2 (pt)
BG (1) BG62443B1 (pt)
BR (1) BR9602630A (pt)
CA (1) CA2223404C (pt)
CZ (1) CZ285878B6 (pt)
DE (1) DE69503066T2 (pt)
DK (1) DK0789697T3 (pt)
DZ (1) DZ2046A1 (pt)
ES (1) ES2117426T3 (pt)
FI (1) FI974441A (pt)
HR (1) HRP960267B1 (pt)
HU (1) HUP9601540A3 (pt)
IL (1) IL118488A (pt)
IS (1) IS4351A (pt)
LV (1) LV11619B (pt)
MA (1) MA23892A1 (pt)
NO (1) NO305599B1 (pt)
NZ (1) NZ286735A (pt)
OA (1) OA10293A (pt)
PE (1) PE38097A1 (pt)
PL (1) PL314604A1 (pt)
RU (1) RU2125571C1 (pt)
SG (1) SG54339A1 (pt)
SI (1) SI9600185A (pt)
SK (1) SK280535B6 (pt)
TN (1) TNSN96084A1 (pt)
TW (2) TW403751B (pt)
UA (1) UA44718C2 (pt)
UY (1) UY25459A1 (pt)
WO (1) WO1996039406A1 (pt)
YU (1) YU34596A (pt)
ZA (1) ZA964647B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) * 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
WO2014109376A1 (ja) * 2013-01-11 2014-07-17 参天製薬株式会社 中栓とその中栓を備えた液体収容容器、及びノズルの先端構造とその構造を備えた液体収容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
WO1995019361A1 (en) * 1994-01-18 1995-07-20 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
NO305599B1 (no) 1999-06-28
MA23892A1 (fr) 1996-12-31
FI974441A0 (fi) 1997-12-05
AR002753A1 (es) 1998-04-29
EP0789697A1 (en) 1997-08-20
HRP960267A2 (en) 1997-08-31
CN1148596A (zh) 1997-04-30
PE38097A1 (es) 1997-10-10
SK71996A3 (en) 1997-03-05
DE69503066D1 (de) 1998-07-23
ES2117426T3 (es) 1998-08-01
JPH10506650A (ja) 1998-06-30
HUP9601540A2 (en) 1997-02-28
KR100191989B1 (ko) 1999-06-15
WO1996039406A1 (en) 1996-12-12
DK0789697T3 (da) 1998-10-19
BG62443B1 (bg) 1999-11-30
RU2125571C1 (ru) 1999-01-27
AU5474996A (en) 1996-12-19
TW403751B (en) 2000-09-01
JP3145715B2 (ja) 2001-03-12
CA2223404C (en) 2001-01-16
LV11619A (lv) 1996-12-20
US5763454A (en) 1998-06-09
NO962321D0 (no) 1996-06-05
TW580389B (en) 2004-03-21
NZ286735A (en) 1998-01-26
HU9601540D0 (en) 1996-07-29
HUP9601540A3 (en) 1997-05-28
DZ2046A1 (fr) 2002-10-22
CA2223404A1 (en) 1996-12-12
SI9600185A (en) 1997-04-30
SG54339A1 (en) 1998-11-16
CN1055474C (zh) 2000-08-16
TNSN96084A1 (fr) 2005-03-15
DE69503066T2 (de) 1998-10-15
SK280535B6 (sk) 2000-03-13
CZ285878B6 (cs) 1999-11-17
IS4351A (is) 1996-12-07
EP0789697B1 (en) 1998-06-17
YU34596A (sh) 1999-03-04
UA44718C2 (uk) 2002-03-15
HRP960267B1 (en) 2000-06-30
NO962321L (no) 1996-12-09
AU703634B2 (en) 1999-03-25
OA10293A (en) 1997-09-19
UY25459A1 (es) 1999-11-17
PL314604A1 (en) 1996-12-09
CZ162596A3 (cs) 1998-09-16
BG100639A (bg) 1997-02-28
ZA964647B (en) 1997-10-22
MX9709873A (es) 1998-03-31
IL118488A0 (en) 1996-09-12
KR970001352A (ko) 1997-01-24
LV11619B (en) 1997-04-20
FI974441A (fi) 1997-12-05
IL118488A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
BR9602630A (pt) Acido7-([1alfa,5alfa,6alfa])-6-amino-3-azabiciclo[3.1.0.]hex-3-il)-6-flúor-1-(2,4-difluorofenil)-1,4-di-hidro-4-oxo-1,8-naftiridina-3-carboxílico, composção farmacêutica método de tratamento de uma infecção bacteriana e processo para a preparação do composto
AU6714890A (en) Method for disinfecting medical materials
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
TJ270B (en) 5,6-Dichlorobenzimidazole derivatives process for their preparation pharmaceutical composition and method of treatment or prophylaxis of virus infections
DE59711622D1 (de) Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
HUP9900625A3 (en) Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds
AU7640696A (en) Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
EP0771788A3 (de) Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU4524889A (en) Method for the treatment of periodontal disease
BR9708930A (pt) Composto derivado de 3-descladinose-2,3-anidro-eritromicina ou um seu sal ou éster farmaceuticamente aceitável processo para a preparação do composto composição farmacêutica e processo de tratamento de infecções bacterianas
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
DE58905246D1 (de) Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE59604829D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
AU7257891A (en) New benzimidazole derivatives, method for preparing them and their pharmaceutical use
DE59510180D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
AU4393497A (en) Method for the sterilization of biological materials
AP9400656A0 (en) Naphthyl derivative for treatment method
DE59310153D1 (de) Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
AU3934689A (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
GR3035710T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO DE ACORDO COM O ART. 8O DA LPI.